Amyloidosis, Primary Cutaneous: Clinical Trials

5 trials for Amyloidosis, Primary Cutaneous, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting, 1 recruiting. 3 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Not yet recruiting 1
Phase 41Recruiting 1

Follow Amyloidosis, Primary Cutaneous: new trials by email Literature Review of Amyloidosis, Primary Cutaneous trials Research Report on Amyloidosis, Primary Cutaneous

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Stapokibart for Primary Cutaneous Amyloidosis
Stapokibart, Placebo drug - Primary Cutaneous Amyloidosis
Not applicableNot yet recruitingFirst Affiliated Hospital of Chongqing Medical University402025-09-152025-08-27
A Prospective Cohort Study on Primary Cutaneous Amyloidosis
Tofacitinib and Acitretin Capsules., Acitretin Capsules. - Primary Cutaneous Amyloidosis
Phase 4RecruitingArmy Medical University, China562025-03-012025-08-13
Efficacy of Methylene Blue Mediated Photodynamic Therapy for Primary Localized Cutaneous Amyloidosis Treatment in Asians
Methylene blue-mediated photodynamic therapy - Lichen Amyloidosis
Not applicableCompletedChulalongkorn University152022-05-012026-05-13
Efficacy of 308-nm Excimer Laser for Primary Localized Cutaneous Amyloidosis Treatment in Asians
308-nm excimer laser - Lichen Amyloidosis
Not applicableCompletedChulalongkorn University152022-01-312026-05-13
Natural History of Severe Allergic Inflammation and Reactions
PGM3 Deficiency, Eosinophilic and/or Atopic Dermatitis
CompletedNational Institute of Allergy and Infectious Diseases (NIAID)9452010-07-122026-10-16

Narrower conditions

Anaphylaxis (1)  ·  Dermatitis (1)  ·  Eosinophilia (1)  ·  Hereditary alpha-tryptasemia syndrome (1)

Broader conditions

Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Immediate (1)  ·  Immune System Diseases (1)  ·  Leukocyte Disorders (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Acitretin (1)  ·  Lasers, Excimer (1)  ·  tofacitinib (1)

Sponsors

Chulalongkorn University (2)  ·  Army Medical University, China (1)  ·  First Affiliated Hospital of Chongqing Medical University (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

Thailand (2)  ·  China (1)  ·  United States (1)

Top investigators

Einapak Amnarttrakul, M.D. (2)  ·  Pamela A Frischmeyer-Guerrerio, M.D. (1)  ·  Rui Yin, MD (1)

Results publications

PMID 27643438